Liu Naifeng, Wu Guoqiu, Li Hui, Li Linxian, Xing Honglei, Zhang Cheng, Lu Huixia
Institute of Cardiovascular disease of Zhongda Hospital, Southeast University, Nanjing 210009, China.
Int Immunopharmacol. 2009 Mar;9(3):291-7. doi: 10.1016/j.intimp.2008.11.015. Epub 2008 Dec 25.
The aim of this study was to isolate a peptide binding to an antibody against CTGF C-terminal domain from the peptide library and to evaluate its immunological and biological activities. A phage display 12-mer peptide library was screened using anti-CTGF/C antibody as the target. Ten of the positive clones were sequenced after three rounds bio-panning. The DNA encoding peptide ZD521 was cloned and expressed as the fusion protein(TrxA-ZD521). The specificity of ZD521 to anti-CTGF/C antibody was determined by competitive inhibition assay. Mice were immunized with purified fusion protein(TrxA-ZD521) and the anti-peptide or anti-CTGF response of antiserum was also tested by enzyme-linked immunoabsorbent assay (ELISA) and Western blot. The inhibition effect of anti-serum on proliferation of kidney mesangial cells was evaluated by MTT. A peptide ZD521(GEPQTKLFSFPL) that could specifically recognize anti-CTGF/C antibody was isolated. No sequence homology was found between ZD521 and CTGF/C. The purified TrxA-ZD521 could specifically bind to anti-CTGF/C antibody and block the binding of anti-CTGF/C antibody to CTGF/C and native CTGF(mesangial cell lysate). Moreover, the antiserum from mice immunized with TrxA-ZD521 could also bind to CTGF/C recombinant protein and native CTGF, as well as significantly inhibit the proliferation of kidney mesangial cells induced by CTGF/C. Therefore, ZD521 might be a conformational epitope of CTGF which is potentially useful to be developed as a vaccine for prevention and treatment of fibrosis disorders.
本研究的目的是从肽库中分离出一种与抗结缔组织生长因子(CTGF)C末端结构域抗体结合的肽,并评估其免疫活性和生物学活性。以抗CTGF/C抗体为靶标筛选噬菌体展示12肽库。三轮生物淘选后对10个阳性克隆进行测序。克隆编码肽ZD521的DNA并表达为融合蛋白(TrxA-ZD521)。通过竞争抑制试验确定ZD521与抗CTGF/C抗体的特异性。用纯化的融合蛋白(TrxA-ZD521)免疫小鼠,并通过酶联免疫吸附测定(ELISA)和蛋白质印迹法检测抗血清的抗肽或抗CTGF反应。通过MTT评估抗血清对肾系膜细胞增殖的抑制作用。分离出一种能特异性识别抗CTGF/C抗体的肽ZD521(GEPQTKLFSFPL)。ZD521与CTGF/C之间未发现序列同源性。纯化的TrxA-ZD521能特异性结合抗CTGF/C抗体,并阻断抗CTGF/C抗体与CTGF/C及天然CTGF(系膜细胞裂解物)的结合。此外,用TrxA-ZD521免疫小鼠获得的抗血清也能与CTGF/C重组蛋白和天然CTGF结合,并显著抑制CTGF/C诱导的肾系膜细胞增殖。因此,ZD521可能是CTGF的一个构象表位,有望开发成为预防和治疗纤维化疾病的疫苗。